Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose
NCT02494492
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
SUSPENDED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Uveitis
Interventions
OTHER:
intravitreous administration of regulator T-cells
Sponsor
Assistance Publique - Hôpitaux de Paris